From: Whole exome sequencing in a sample of Egyptian patients with covert cerebral small vessel disease
Age | Mean ± SD | 65.93 ± 8.8 |
n | Percentage | ||
---|---|---|---|
Gender | Males | 19 | 63.33% |
Females | 11 | 36.66% | |
Vascular risk factors | Hypertension | 19 | 63.33% |
Diabetes | 11 | 36.66% | |
Dyslipidaemia | 10 | 33.33% | |
Current Smoking | 7 | 23.33% | |
Ex-smoker | 6 | 20% | |
Ischemic heart | 5 | 16.66% | |
Family history of similar condition | 3 | 10% | |
Sleep apnea | 1 | 3.33% | |
Atrial Fibrillation | 0 | 0% | |
Previous Stroke | 0 | 0% | |
First presenting symptom | Cognitive impairment | 18 | 60% |
Gait abnormality | 10 | 33.33% | |
Others | 2 | 6.66% | |
Age of onset | Mean ± SD | 63.66 ± 8.8 | |
Duration of symptoms | Mean ± SD | 2.1 ± 1.12 | |
Fazekas scale | 1 | 2 | 6.66% |
2 | 18 | 60% | |
3 | 10 | 33.33% | |
MoCA | Mean ± SD | 17.633 ± 4.97 | |
BBS | Mean ± SD | 33.68 ± 12.2 | |
10m walk SSS | Mean ± SD | 0.40 ± 0.11 |